Approaching the spring festival, the 9th T-cell lymphoma forum (TCLF forum) was held in San Francisco, USA from January 19 to 21, 2016. Eleven top experts from China’s companies including CHIPSCREEN BIOSCIENCES, participated in the meeting. The meeting focused on " histone deacetylase inhibitor (HDACi)", which was mentioned and discussed by many scholars. The importance of HDACi drugs in T-cell lymphoma was also discussed. What is worth paying attention to is that the Chinese experts made four oral reports at this meeting, 11 wall newspapers, and 4 of them were about the interpretation of clinical data of Chidamide. Dr. Ning Zhiqiang, the vice president of CHIPSCREEN BIOSCIENCES, reported on the use and registration of Chidamide in various countries in the world at the conference, which promoted Chidamide's position in the international community.

On January 21, the meeting was successfully concluded. Scholars at home and abroad highly praised the meeting and jointly looked forward to the meeting next year.